ABOUT US
MANAGEMENT
BEN PLESS, CEO, FOUNDER, DIRECTOR
Over 25 years experience in medical device development and leadership at multi-
national and start-up companies, including Ventritex, St. Jude Medica, NeuroPace
and Autonomic Technologies. MIT graduate, inventor of over 140 patents.
.jpg)
CRAIG PATTERSON, CFO, VICE PRESIDENT BUSINESS DEVELOPMENT
Over 20+ years experience in medical devices, including 7 years international
(Europe). Raised over $70M of private equity/debt. Worked in multi-national
companies as well as start-ups including Autonomic Technologies.
Brett Wingeier, R&D CONSULTANT
Experienced engineering leader and product executive with 20+ years developing and commercializing medtech from active implantables to app-enabled wearables. PhD biomedical engineer focusing on complex biosignals. Ex NeuroPace, Halo Neuroscience, and Magnus Medical.
SHANNON SCHUETZ, SR. DIR. OF OPERATIONS
Over 15 years of experience in the commercialization of medical devices including
intellectual property, technical, market and contracting analysis and strategy.
Worked at Avation Medical, Autonomic Technologies and Cleveland Clinic
Innovations/New Ventures.
ADVISORS
ROBERT LANGER, PHD, FOUNDER
David H. Koch Institute Professor at Massachusetts Institute of Technology,
prolific inventor and most cited engineer in history.
JEREMY RUSKIN, MD, FOUNDER
World-renowned cardiologist and electrophysiologist. Founder and Director
Emeritus of the Cardiac Arrhythmia Service at Massachusetts General Hospital
and Professor of Medicine at Harvard Medical School.
GIOVANNI TRAVERSO, MD, PHD FOUNDER, DIRECTOR
Gastroenterologist and biomedical engineer. Assistant Professor in the Department
of Mechanical Engineering, Massachusetts Institute of Technology, and at Brigham
and Women's Hospital, Harvard Medical School. Current research focused on
developing the next generation of drug delivery systems to enable safe and efficient
delivery of therapeutics through the gastrointestinal tract, as well as developing
novel ingestible electronic devices for sensing a broad array of physiologic and
pathophysiologic parameters.
ALI REZAI, MD, SENIOR SCIENCE ADVISOR
Executive Chair, VP of Neuroscience and John D. Rockefeller IV.
Tenured Professor in Neuroscience at West Virginia University.
CLINICAL ADVISORS
PAIN AND ADDICTION MEDICINE SPECIALISTS
_1)-min.jpg)
YEASHVANT NAVALGUND, MD
Assistant Professor, Dept of Anesthesiology/Division of Pain Management at West Virginia University. Founder, Former President of the Pennsylvania Pain Society. Founder of DNAPAIN clinics.
DAN CICCARONE, MD
Professor, Family Community Medicine at the University of California, San Francisco. Author and advocate for CDC Naloxone co-prescribing with high-dose opioids policy.
JAMES BERRY, DO
Chair, Department of Behavioral Medicine & Psychiatry. Director, Addiction Services and Medical Director, J.W. Ruby Memorial Hospital at West Virginia University.
PARTNERS
Technology licensed from Mass General Brigham and its affiliates and Massachusetts Institute of Technology to enhance CELERO System’s technology platform.
